tiprankstipranks
Quoin Pharmaceuticals Provides Corporate Update and Announces First  Quarter 2024 Financial Results
PremiumPress ReleasesQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
2M ago
Quoin Pharmaceuticals reports Q1 EPS ($1.11) vs. ($4.09) last year
PremiumThe Fly
Quoin Pharmaceuticals reports Q1 EPS ($1.11) vs. ($4.09) last year
2M ago
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
PremiumPress Releases
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
2M ago
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
PremiumPress ReleasesQuoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
7M ago
Quoin Pharmaceuticals announces FDA clearance for plan for QRX003 trials
PremiumThe Fly
Quoin Pharmaceuticals announces FDA clearance for plan for QRX003 trials
7M ago
Quoin Pharmaceuticals reports Q3 EPS ($1.95), consensus ($2.72)
PremiumThe Fly
Quoin Pharmaceuticals reports Q3 EPS ($1.95), consensus ($2.72)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100